Regulus Therapeutics completes dosing in early-stage kidney disease trial
April 15 2021 - 8:35AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Apr 2023 to Apr 2024